Catalyst Pharmaceuticals (CPRX) Other Working Capital Changes (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) reported Other Working Capital Changes of -$106000.0 for Q1 2026, down 9.28% on a YoY basis from -$116840.9 in Q1 2025, and down 122.27% quarter-over-quarter from $476000.0 in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals has reported Other Working Capital Changes for 17 years, with the latest figure at -$106000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 9.28% year-over-year to -$106000.0; the trailing twelve-month figure through Mar 2026 stood at $168000.0 (up 144.56% YoY), and the FY2024 full-year result was $11124.0, up 103.29% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$106000.0, down from $476000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $11.1 million in Q2 2024, with the low at -$7.6 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged $10058.8 across 5 years, with a median of -$89000.0 in 2024.
- The largest YoY upside for Other Working Capital Changes was 2625.12% in 2023 against a maximum downside of 829.44% in 2023.
- Catalyst Pharmaceuticals' Other Working Capital Changes stood at $1.0 million in 2022, then sank by 829.44% to -$7.6 million in 2023, then climbed by 17.72% to -$6.2 million in 2024, then surged by 107.66% to $476000.0 in 2025, then plunged by 122.27% to -$106000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$106000.0 (Q1 2026), $476000.0 (Q4 2025), and -$686000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Catalyst Pharmaceuticals | 3.84 Bn | 3.08 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -106,000.00 |
| Mar 31, 2026 | -106,000.00 |
| Dec 31, 2025 | 476,000.00 |
| Dec 31, 2025 | 476,000.00 |
| Sep 30, 2025 | -686,000.00 |
| Sep 30, 2025 | -686,000.00 |
| Jun 30, 2025 | 484,000.00 |
| Jun 30, 2025 | 484,000.00 |
| Mar 31, 2025 | -97,000.00 |
| Mar 31, 2025 | -97,000.00 |
| Dec 31, 2024 | -6.22 Mn |
| Dec 31, 2024 | -6.22 Mn |
| Sep 30, 2024 | -5.17 Mn |
| Sep 30, 2024 | -5.17 Mn |
| Jun 30, 2024 | 11.10 Mn |
| Jun 30, 2024 | 11.10 Mn |
| Mar 31, 2024 | -89,000.00 |
| Mar 31, 2024 | -89,000.00 |
| Dec 31, 2023 | -7.56 Mn |
| Dec 31, 2023 | -7.56 Mn |